NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
NewLimit is recruiting a Head of Translation to lead our therapeutic programs from discovery to the clinic. Our active programs are focused on restoring youthful hepatic metabolism, vascular endothelial integrity, and T cell immunity in aged and diseased patients.
In this role, you will lead the validation and preclinical development of reprogramming medicines through regulatory filing to early clinical development. You will serve as the company’s senior preclinical development scientist and as a member of our executive team.
As part of your role, you will:
Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Learn more at: https://www.newlimit.com/careers
Discover exciting opportunities in biotechnology. Join innovative companies that are advancing healthcare and life sciences through cutting-edge research and development.
Interested in building your career at New Limit? Get future opportunities sent straight to your email.
Create AlertDiscover similar positions that might interest you
New Limit
New Limit
New Limit
New Limit
New Limit
New Limit